{"transactions":[{"id":1969590,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T11:38:30.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":10250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 5)"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 5)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."}],"balance_after":0,"derivative":{"exercise_price":4.26,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":10250},"source":{"system":"sec-edgar","filing":"0001209191-23-016165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919123016165/doc4.xml","form_type":"4"}},{"id":1969589,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T11:38:30.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 5)"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 5)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."}],"balance_after":0,"derivative":{"exercise_price":9.16,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-016165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919123016165/doc4.xml","form_type":"4"}},{"id":1969588,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T11:38:30.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 5)"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 5)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."}],"balance_after":0,"derivative":{"exercise_price":11.02,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-016165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919123016165/doc4.xml","form_type":"4"}},{"id":1969587,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T11:38:30.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 5)"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 5)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."}],"balance_after":0,"derivative":{"exercise_price":19.59,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-016165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919123016165/doc4.xml","form_type":"4"}},{"id":1969586,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T11:38:30.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 5)"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 5)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."}],"balance_after":0,"derivative":{"exercise_price":13.29,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-016165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919123016165/doc4.xml","form_type":"4"}},{"id":1969585,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T11:38:30.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 5)"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 5)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."}],"balance_after":0,"derivative":{"exercise_price":12.96,"expiration_date":"2026-06-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-016165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919123016165/doc4.xml","form_type":"4"}},{"id":1969584,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T11:38:30.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 5)"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 5)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."}],"balance_after":0,"derivative":{"exercise_price":16.42,"expiration_date":"2025-06-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-016165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919123016165/doc4.xml","form_type":"4"}},{"id":1969583,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-06T11:38:30.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":16400,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This line item represents unvested time-based restricted stock units with respect to the Issuer's common stock (\"RSUs\") held by the Reporting Person. Pursuant to the terms of the Merger Agreement, at the Effective Time, each unvested RSU that was outstanding immediately prior to the Effective Time was cancelled and converted into the right to receive, for each Share underlying such RSU, the Per Share Consideration, subject to withholding of applicable taxes and without interest."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This line item represents unvested time-based restricted stock units with respect to the Issuer's common stock (\"RSUs\") held by the Reporting Person. Pursuant to the terms of the Merger Agreement, at the Effective Time, each unvested RSU that was outstanding immediately prior to the Effective Time was cancelled and converted into the right to receive, for each Share underlying such RSU, the Per Share Consideration, subject to withholding of applicable taxes and without interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-016165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919123016165/doc4.xml","form_type":"4"}},{"id":1969582,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-06T11:38:30.000Z","date":"2023-03-06","kind":"other","acquired":false,"shares":13088,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 19, 2023, by and among Concert Pharmaceuticals, Inc. (the \"Issuer\"), Sun Pharmaceutical Industries Ltd. (\"Parent\") and Foliage Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer, effective as of March 6, 2023 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $8.00 in cash (the \"Cash Amount\"), plus one non-tradeable contingent value right (a \"CVR,\" and together with the Cash Amount, the \"Per Share Consideration\"), which represents the right to receive contingent payments of up to $3.50 per Share, in cash, (continued in Footnote 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"in the aggregate, upon the achievement of certain milestones (such applicable payment, each, a \"Milestone Payment\") prior to December 31, 2029, subject to any applicable withholding of taxes and without interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-016165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919123016165/doc4.xml","form_type":"4"}},{"id":2135723,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-10-18T16:25:25.000Z","date":"2022-10-14","kind":"exercise","acquired":false,"shares":3539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.88,"expiration_date":"2022-11-12","underlying":"Common Stock","underlying_shares":3539},"source":{"system":"sec-edgar","filing":"0001209191-22-053967","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919122053967/doc4.xml","form_type":"4"}},{"id":2135722,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-18T16:25:25.000Z","date":"2022-10-14","kind":"sale","acquired":false,"shares":3539,"price":6.09,"value":21552.51,"ownership":{"direct":true},"balance_after":29488,"source":{"system":"sec-edgar","filing":"0001209191-22-053967","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919122053967/doc4.xml","form_type":"4"}},{"id":2135721,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-18T16:25:25.000Z","date":"2022-10-14","kind":"exercise","acquired":true,"shares":3539,"price":2.88,"value":10192.32,"ownership":{"direct":true},"balance_after":33027,"source":{"system":"sec-edgar","filing":"0001209191-22-053967","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919122053967/doc4.xml","form_type":"4"}},{"id":2234467,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T16:15:36.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":16400,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. These RSUs vest in full on the earlier of (i) June 9, 2023 and (ii) the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders. The amount listed represents the maximum number of shares of Common Stock of the Issuer that may be delivered pursuant to the grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":29488,"source":{"system":"sec-edgar","filing":"0001209191-22-036288","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919122036288/doc4.xml","form_type":"4"}},{"id":2672365,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-11T08:41:20.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":10250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in equal quarterly installments over a one-year period through June 10, 2022, provided that such option shall vest in full on the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders (if earlier than June 10, 2022)."}],"balance_after":10250,"derivative":{"exercise_price":4.26,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":10250},"source":{"system":"sec-edgar","filing":"0001209191-21-039746","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919121039746/doc4.xml","form_type":"4"}},{"id":2672364,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-11T08:41:20.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":5125,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. These RSUs vest in full on the earlier of (i) June 10, 2022 and (ii) the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders. The amount listed represents the maximum number of shares of Common Stock of the Issuer that may be delivered pursuant to the grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":13088,"source":{"system":"sec-edgar","filing":"0001209191-21-039746","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919121039746/doc4.xml","form_type":"4"}},{"id":3001151,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-10-23T17:34:22.000Z","date":"2020-10-23","kind":"disposition_to_issuer","acquired":false,"shares":3718,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"In connection with the consummation of the Merger, at the Effective Time, each restricted stock unit to acquire shares of Common Stock (\"Restricted Stock Unit\") that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash equal to (A) the Offer Price, multiplied by (B) the total number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the consummation of the Merger, at the Effective Time, each restricted stock unit to acquire shares of Common Stock (\"Restricted Stock Unit\") that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash equal to (A) the Offer Price, multiplied by (B) the total number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"In connection with the consummation of the Merger, at the Effective Time, each restricted stock unit to acquire shares of Common Stock (\"Restricted Stock Unit\") that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash equal to (A) the Offer Price, multiplied by (B) the total number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"In connection with the consummation of the Merger, at the Effective Time, each restricted stock unit to acquire shares of Common Stock (\"Restricted Stock Unit\") that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash equal to (A) the Offer Price, multiplied by (B) the total number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3718},"source":{"system":"sec-edgar","filing":"0001104659-20-117801","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920117801/a4.xml","form_type":"4"}},{"id":3001150,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-23T17:34:22.000Z","date":"2020-10-23","kind":"disposition_to_issuer","acquired":false,"shares":52614,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":52614},"source":{"system":"sec-edgar","filing":"0001104659-20-117801","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920117801/a4.xml","form_type":"4"}},{"id":3001149,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-23T17:34:22.000Z","date":"2020-10-23","kind":"disposition_to_issuer","acquired":false,"shares":13516,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.01 per share, of the Company (\"Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was automatically cancelled and converted into the right to receive $88.00 in cash (the \"Offer Price\"), without interest and subject to required withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.01 per share, of the Company (\"Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was automatically cancelled and converted into the right to receive $88.00 in cash (the \"Offer Price\"), without interest and subject to required withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-117801","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920117801/a4.xml","form_type":"4"}},{"id":3042785,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-09-01T16:01:36.000Z","date":"2020-08-31","kind":"exercise","acquired":false,"shares":3539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.79,"expiration_date":"2020-12-03","underlying":"Common Stock","underlying_shares":3539},"source":{"system":"sec-edgar","filing":"0001209191-20-048893","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919120048893/doc4.xml","form_type":"4"}},{"id":3042784,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-01T16:01:36.000Z","date":"2020-08-31","kind":"exercise","acquired":true,"shares":3539,"price":3.79,"value":13412.81,"ownership":{"direct":true},"balance_after":7963,"source":{"system":"sec-edgar","filing":"0001209191-20-048893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919120048893/doc4.xml","form_type":"4"}},{"id":3103714,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-22T17:20:37.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":6540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Such grants of restricted stock units and stock options were made automatically pursuant to the Issuer's compensation policy for non-employee directors as of the date of the Issuer's 2020 annual meeting of stockholders, which occurred on June 18, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":6540,"derivative":{"exercise_price":33.62,"exercise_date":"2021-06-18","expiration_date":"2030-06-18","underlying":"Common Stock, par value $0.01 per share","underlying_shares":6540},"source":{"system":"sec-edgar","filing":"0001104659-20-075696","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920075696/a4.xml","form_type":"4"}},{"id":3103713,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value per share","published_at":"2020-06-22T17:20:37.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":3718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Such grants of restricted stock units and stock options were made automatically pursuant to the Issuer's compensation policy for non-employee directors as of the date of the Issuer's 2020 annual meeting of stockholders, which occurred on June 18, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":17234,"source":{"system":"sec-edgar","filing":"0001104659-20-075696","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920075696/a4.xml","form_type":"4"}},{"id":3112115,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-12T17:04:44.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in equal quarterly installments over a one-year period through June 11, 2021, provided that such option shall vest in full on the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders (if earlier than June 11, 2021)."}],"balance_after":10000,"derivative":{"exercise_price":9.16,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-036348","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919120036348/doc4.xml","form_type":"4"}},{"id":3361393,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-22T06:23:27.000Z","date":"2019-11-20","kind":"exercise","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable."}],"balance_after":502752,"derivative":{"exercise_price":0.04,"expiration_date":"2022-03-27","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001127602-19-033520","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000112760219033520/form4.xml","form_type":"4"}},{"id":3361392,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-11-22T06:23:27.000Z","date":"2019-11-20","kind":"sale","acquired":false,"shares":200000,"price":20.18,"value":4036000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares sold in multiple transactions at prices ranging from $20.00 to $20.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":3924,"source":{"system":"sec-edgar","filing":"0001127602-19-033520","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000112760219033520/form4.xml","form_type":"4"}},{"id":3361391,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-11-22T06:23:27.000Z","date":"2019-11-20","kind":"exercise","acquired":true,"shares":200000,"price":0.04,"value":8000.0,"ownership":{"direct":true},"balance_after":203924,"source":{"system":"sec-edgar","filing":"0001127602-19-033520","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000112760219033520/form4.xml","form_type":"4"}},{"id":3411053,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-18T16:11:39.000Z","date":"2019-09-17","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable."}],"balance_after":702752,"derivative":{"exercise_price":0.04,"expiration_date":"2022-03-27","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001127602-19-028728","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000112760219028728/form4.xml","form_type":"4"}},{"id":3411052,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-18T16:11:39.000Z","date":"2019-09-17","kind":"sale","acquired":false,"shares":100000,"price":17.63,"value":1763000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $17.31 to $17.94.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":3924,"source":{"system":"sec-edgar","filing":"0001127602-19-028728","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000112760219028728/form4.xml","form_type":"4"}},{"id":3411051,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-18T16:11:39.000Z","date":"2019-09-17","kind":"exercise","acquired":true,"shares":100000,"price":0.04,"value":4000.0,"ownership":{"direct":true},"balance_after":103924,"source":{"system":"sec-edgar","filing":"0001127602-19-028728","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000112760219028728/form4.xml","form_type":"4"}},{"id":3441287,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option (right to buy)","published_at":"2019-08-12T16:00:40.000Z","date":"2019-08-08","kind":"exercise","acquired":false,"shares":3539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.41,"expiration_date":"2019-12-10","underlying":"Common Stock","underlying_shares":3539},"source":{"system":"sec-edgar","filing":"0001209191-19-045483","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919119045483/doc4.xml","form_type":"4"}},{"id":3441286,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-12T16:00:40.000Z","date":"2019-08-08","kind":"sale","acquired":false,"shares":3539,"price":10.31,"value":36487.09,"ownership":{"direct":true},"balance_after":4424,"source":{"system":"sec-edgar","filing":"0001209191-19-045483","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919119045483/doc4.xml","form_type":"4"}},{"id":3441285,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-12T16:00:40.000Z","date":"2019-08-08","kind":"exercise","acquired":true,"shares":3539,"price":4.41,"value":15606.99,"ownership":{"direct":true},"balance_after":7963,"source":{"system":"sec-edgar","filing":"0001209191-19-045483","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919119045483/doc4.xml","form_type":"4"}},{"id":3476181,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-28T16:14:30.000Z","date":"2019-06-27","kind":"grant","acquired":true,"shares":54660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will become fully vested and exercisable on the earlier of June 27, 2020, or the next Annual Meeting of Stockholders, subject to the recipient's continued service."}],"balance_after":54660,"derivative":{"exercise_price":14.34,"expiration_date":"2029-06-27","underlying":"Common Stock","underlying_shares":54660},"source":{"system":"sec-edgar","filing":"0001127602-19-023015","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000112760219023015/form4.xml","form_type":"4"}},{"id":3488254,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2019-06-17T21:06:05.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in equal quarterly installments over a one-year period, through and including June 13, 2020."}],"balance_after":10000,"derivative":{"exercise_price":11.02,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-037564","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919119037564/doc4.xml","form_type":"4"}},{"id":3495040,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-11T16:29:45.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":17077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Such grants of restricted stock units and stock options were made automatically pursuant to the Issuer's compensation policy for non-employee directors as of the date of the Issuer's 2019 annual meeting of stockholders, which occurred on June 7, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":17077,"derivative":{"exercise_price":12.93,"exercise_date":"2020-06-07","expiration_date":"2026-06-07","underlying":"Common Stock, par value $0.01 per share","underlying_shares":17077},"source":{"system":"sec-edgar","filing":"0001104659-19-034788","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465919034788/a4.xml","form_type":"4"}},{"id":3495039,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value per share","published_at":"2019-06-11T16:29:45.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":9667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Such grants of restricted stock units and stock options were made automatically pursuant to the Issuer's compensation policy for non-employee directors as of the date of the Issuer's 2019 annual meeting of stockholders, which occurred on June 7, 2019."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":13516,"source":{"system":"sec-edgar","filing":"0001104659-19-034788","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465919034788/a4.xml","form_type":"4"}},{"id":3813722,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2018-09-18T14:54:20.000Z","date":"2018-04-02","kind":"grant","acquired":true,"shares":6497,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Such grants of restricted stock units and stock options were made automatically pursuant to the Issuer's compensation policy for non-employee directors as of the date of the Issuer's 2018 annual meeting of stockholders, which occurred on April 2, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":6497,"derivative":{"exercise_price":14.29,"exercise_date":"2019-04-02","expiration_date":"2025-04-02","underlying":"Common Stock, par value $0.01 per share","underlying_shares":6497},"source":{"system":"sec-edgar","filing":"0001171843-18-006603","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/722830/000117184318006603/ownership.xml","form_type":"4"}},{"id":3813721,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value per share","published_at":"2018-09-18T14:54:20.000Z","date":"2018-04-02","kind":"grant","acquired":true,"shares":3849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Such grants of restricted stock units and stock options were made automatically pursuant to the Issuer's compensation policy for non-employee directors as of the date of the Issuer's 2018 annual meeting of stockholders, which occurred on April 2, 2018."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":3849,"source":{"system":"sec-edgar","filing":"0001171843-18-006603","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000117184318006603/ownership.xml","form_type":"4"}},{"id":3861001,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-26T15:52:21.000Z","date":"2018-07-25","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in 12 successive equal monthly installments measured from June 6, 2018."}],"balance_after":10000,"derivative":{"exercise_price":0.82,"expiration_date":"2028-07-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001615219-18-000043","document":"wf-form4_153263472568123.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000161521918000043/wf-form4_153263472568123.xml","form_type":"4"}},{"id":3889081,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-19T19:03:52.000Z","date":"2018-06-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 15, 2019 or the day immediately prior to the company's 2019 annual meeting of shareholders."}],"balance_after":10000,"derivative":{"exercise_price":12.75,"expiration_date":"2028-06-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001638599-18-000674","document":"doc4_5484.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000163859918000674/doc4_5484.xml","form_type":"4"}},{"id":3890929,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2018-06-18T18:59:38.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in equal quarterly installments over a one-year period, through and including June 14, 2019."}],"balance_after":10000,"derivative":{"exercise_price":19.59,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-18-017079","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000089924318017079/doc4.xml","form_type":"4"}},{"id":4250225,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-27T08:50:22.000Z","date":"2017-07-26","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in 12 successive equal monthly installments measured from July 26, 2017."}],"balance_after":12000,"derivative":{"exercise_price":4.08,"expiration_date":"2027-07-26","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001615219-17-000050","document":"wf-form4_150115980932435.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000161521917000050/wf-form4_150115980932435.xml","form_type":"4"}},{"id":4262919,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2017-07-06T18:05:41.000Z","date":"2017-07-03","kind":"grant","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22500,"derivative":{"exercise_price":9.02,"exercise_date":"2018-07-03","expiration_date":"2024-07-03","underlying":"Common Stock, par value $0.01 per share","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001104659-17-043900","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465917043900/a4.xml","form_type":"4"}},{"id":4276281,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-20T16:42:20.000Z","date":"2017-06-16","kind":"grant","acquired":true,"shares":6410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 16, 2018 or the day immediately prior to the company's 2018 annual meeting of shareholders."}],"balance_after":6410,"derivative":{"exercise_price":17.47,"expiration_date":"2027-06-15","underlying":"Common Stock","underlying_shares":6410},"source":{"system":"sec-edgar","filing":"0001638599-17-000640","document":"doc4_4810.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000163859917000640/doc4_4810.xml","form_type":"4"}},{"id":4277640,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2017-06-19T07:28:46.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in equal quarterly installments over a one-year period, through and including June 15, 2018."}],"balance_after":10000,"derivative":{"exercise_price":13.29,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-040706","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919117040706/doc4.xml","form_type":"4"}},{"id":4310957,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Share Option (right to buy)","published_at":"2017-05-22T22:38:51.000Z","date":"2017-02-10","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was approved by the Board of Directors of the Issuer on February 10, 2017, subject to approval by the Issuer's stockholders, at the 2017 Annual Meeting of Stockholders, of an amendment of the Issuer's 2010 Long Term Incentive and Stock Award Plan (the \"Plan\"), including an increase in the number of shares reserved for issuance under the Plan (the \"Amendment\"). The Stockholders of the Issuer approved the Amendment on May 18, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to this option shall vest in equal monthly installments over three years from the grant date."}],"balance_after":8000,"derivative":{"exercise_price":4.03,"expiration_date":"2027-02-10","underlying":"Common Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0000791908-17-000023","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000079190817000023/edgardoc.xml","form_type":"4"}},{"id":4547199,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option (right to buy)","published_at":"2016-11-21T16:10:28.000Z","date":"2016-11-14","kind":"exercise","acquired":false,"shares":22123,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.13,"expiration_date":"2017-06-04","underlying":"Common Stock","underlying_shares":22123},"source":{"system":"sec-edgar","filing":"0001209191-16-151428","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919116151428/doc4.xml","form_type":"4"}},{"id":4547198,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-21T16:10:28.000Z","date":"2016-11-14","kind":"sale","acquired":false,"shares":22123,"price":9.81,"value":217026.63,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-16-151428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919116151428/doc4.xml","form_type":"4"}},{"id":4547197,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":115931,"kind":"person","name":"HUTT PETER BARTON","position":1,"cik":"0001171527","reported_name":"HUTT PETER BARTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-21T16:10:28.000Z","date":"2016-11-14","kind":"exercise","acquired":true,"shares":22123,"price":1.13,"value":24998.99,"ownership":{"direct":true},"balance_after":22123,"source":{"system":"sec-edgar","filing":"0001209191-16-151428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171527/000120919116151428/doc4.xml","form_type":"4"}}]}